EUTECNIQ Sciences

See every page on one mapArrow keys move through results · Enter opens · Esc closes

For international ingredient manufacturers Proposed service

EUTECNIQ proposes to turn an international ingredient's evidence into a U.S.-ready file, then find and serve its U.S. buyers

For an ingredient manufacturer outside the United States that wants U.S. customers: what you would provide, what EUTECNIQ would do, the documents produced, the decisions along the way, and what is not promised.

Status. EUTECNIQ Sciences is a company in formation. It has no supplier agreements, no laboratory and no accreditation. Testing would be done by qualified external laboratories until EUTECNIQ has its own.

26CFR rule sets mapped for a botanical ingredient shipment entering the United States; most are your importer's or buyer's duties
Oct 1–Dec 31, 2026renewal window for FDA food facility registrations, repeated every even year (21 CFR 1.230(b))
75 daysminimum notice to FDA before a new dietary ingredient is marketed (21 CFR 190.6(a))
90 daysFDA keeps a notification confidential, then publishes it except trade secrets (21 CFR 190.6(e))
In brief

Your evidence, checked and completed for U.S. rules, with a defined commercial route at the end

Choose your situation to follow the path from the U.S. rules to the documents you would receiveProposed service flow
Rules link to eCFR; most are duties of your U.S. importer or buyer that your evidence supports. Testing would be done by qualified external laboratories until EUTECNIQ has its own. Steps and documents are proposals.
Text version: situations, rules, steps and documents

Your situation

  • Extract manufacturers with an established product Need verified evidence and a U.S. buyer route for an ingredient already sold elsewhere.
  • Growers and primary processors Need identity, contaminant and quality records that U.S. buyers can verify.
  • Makers of a new or changed ingredient Need a regulatory route for the intended U.S. use before anything ships.

U.S. rules your evidence serves

Steps (proposed)

Documents produced

In brief: what you would provide, what EUTECNIQ would do, what you would receive
You would provide

Identity basis, process description, lot data, stability and safety information, regulatory and quality history, samples and commercial terms.

EUTECNIQ would do

Gap assessment, supplier qualification, verification testing through partner laboratories, specification, regulatory strategy, application work and a U.S. commercial route.

Proposed
You would receive

A defined set of documents with agreed ownership, and a decision at each step on whether to continue.

U.S. buyers must verify what they buy, and U.S. rules decide what an ingredient may be used for. EUTECNIQ would close the distance between your current documentation and both.

What you would provide

The work starts from what your company already knows about its ingredient and its process

Only the first row is needed before an NDA. Everything else would be shared under a mutual NDA, in a controlled data room.

Ten kinds of information, one of them before an NDAProposed process
Ten kinds of information a supplier would provide; only the non-confidential summary comes before a mutual NDABefore an NDANon-confidentialsummaryName and form, species andpart, intended U.S. uses,certificationsUnder a mutual NDABotanical identity basisLatin binomial with author,plant part, origin, cultivatedor wild, vouchersUnder a mutual NDAProcess descriptionSolvents, raw material toextract ratio, concentrationand drying, carriersUnder a mutual NDALot dataSpecification andcertificates for severalrecent lots, with methodsand resultsUnder a mutual NDAStabilityProtocol, results andpackagingUnder a mutual NDASafety informationToxicology, history of use,literature, adverse eventsUnder a mutual NDARegulatory and importhistoryFDA registration, U.S.shipments, refusals orimport alerts, otherauthorizationsUnder a mutual NDAQuality systemCertifications, audit reports,complaint, deviation andrecall historyUnder a mutual NDACommercial termsCapacity, lead times,minimum order, pricingstructure, trade termUnder a mutual NDADevelopment samplesRepresentative lots with fulldocumentationTen kinds of information a supplier would provide; only the non-confidential summary comes before a mutual NDABefore an NDANon-confidential summaryName and form, species and part, intended U.S. uses,certificationsUnder a mutual NDABotanical identity basisLatin binomial with author, plant part, origin, cultivated orwild, vouchersUnder a mutual NDAProcess descriptionSolvents, raw material to extract ratio, concentration anddrying, carriersUnder a mutual NDALot dataSpecification and certificates for several recent lots, withmethods and resultsUnder a mutual NDAStabilityProtocol, results and packagingUnder a mutual NDASafety informationToxicology, history of use, literature, adverse eventsUnder a mutual NDARegulatory and import historyFDA registration, U.S. shipments, refusals or import alerts,other authorizationsUnder a mutual NDAQuality systemCertifications, audit reports, complaint, deviation andrecall historyUnder a mutual NDACommercial termsCapacity, lead times, minimum order, pricing structure,trade termUnder a mutual NDADevelopment samplesRepresentative lots with full documentation
Botanical naming in a notification: 21 CFR 190.6(b) (Latin binomial including the author). Everything after the first card would be shared under a mutual NDA, in a controlled data room.
Text version: the ten kinds of information, what each includes and why it is needed
InformationWhat it includesWhy it is needed
Non-confidential summaryIngredient name and form, plant species and part, intended U.S. uses, existing certifications, company contactDecide whether there is a fit before anything confidential is exchanged
Botanical identity basisLatin binomial with author, plant part, geographic origin, cultivated or wild-collected, any voucher or reference materialIdentity method design; a U.S. new-dietary-ingredient notification names a botanical by its Latin binomial including the author (21 CFR 190.6(b))
Process descriptionExtraction solvents, ratio of raw material to extract, concentration and drying steps, carriers and excipientsComposition, residual solvents, and whether the process changes regulatory status
Lot dataCurrent specification and certificates of analysis for several recent lots, with methods, limits and actual resultsBaseline for verification testing and for a buyer's reliance on certificates
StabilityStudy protocol, results and packagingRetest date under shipping and storage conditions
Safety informationToxicology studies, history of use, published literature, adverse-event informationSafety evidence and its gaps for the intended use and intake
Regulatory and import historyFDA food facility registration status, U.S. shipments, refusals or import alerts, authorizations in other marketsImport risk and the regulatory starting point
Quality systemCertifications, recent audit reports, complaint, deviation and recall historySupplier qualification and audit planning
Commercial termsCapacity, lead times, minimum order, pricing structure and trade term, preferred U.S. modelChoice of commercial model and landed-cost assessment
Development samplesRepresentative lots shipped with full documentationVerification testing; FDA prior notice applies to samples imported for testing (21 CFR 1.277(a))
What EUTECNIQ would do

EUTECNIQ would close the gap between your documentation and what U.S. buyers and rules require

Each step would be scoped and priced before it starts.

At each of six steps: what you would provide, what EUTECNIQ would do, where partners would actProposed External partners
Six proposed engagement steps with what the supplier would provide, what EUTECNIQ would do and where qualified partners would act at each stepGap assessmentQualificationVerificationRegulatorystrategyApplication workU.S. routeYou would provideNon-confidentialsummary first;documents undera mutual NDAQuality system:certifications,audit reports,complaint,deviation andrecall historyLot data withmethods, limitsand results;stability;developmentsamplesIdentity basis,processdescription, safetyinformation,regulatory andimport historyRepresentativematerialCapacity, leadtimes, minimumorder, pricing andtrade termEUTECNIQ woulddoProposedYour documentsagainst U.S. rulesand buyerexpectations; costand time to closeeach gapAudit plan,corrective actions,draft qualityagreementPlans the testing,reviews all data,owns thespecificationCategory, NDIstatus, claimslimits, importroles;market-access fileFormats andstability, whereusefulPresents theingredient to U.S.buyers under thechosen model;U.S. technical datapackageQualified partnersExternalThird-partyauditors whereEUTECNIQ cannotattendExternallaboratories:identity,fingerprint,contaminants,stabilityRegulatorycounsel for legalconclusionsCommercialcounsel; customsbrokers andwarehouses oncegoods moveEach step would be scoped and priced before it starts. Testing by external laboratories until EUTECNIQ has its own.Six proposed engagement steps with what the supplier would provide, what EUTECNIQ would do and where qualified partners would act at each step1. Gap assessmentYou would provideNon-confidential summary first; documents undera mutual NDAEUTECNIQ would doYour documents against U.S. rules and buyerexpectations; cost and time to close each gap2. QualificationYou would provideQuality system: certifications, audit reports,complaint, deviation and recall historyEUTECNIQ would doAudit plan, corrective actions, draft qualityagreementQualified partnersThird-party auditors where EUTECNIQ cannotattend3. VerificationYou would provideLot data with methods, limits and results; stability;development samplesEUTECNIQ would doPlans the testing, reviews all data, owns thespecificationQualified partnersExternal laboratories: identity, fingerprint,contaminants, stability4. Regulatory strategyYou would provideIdentity basis, process description, safetyinformation, regulatory and import historyEUTECNIQ would doCategory, NDI status, claims limits, import roles;market-access fileQualified partnersRegulatory counsel for legal conclusions5. Application workYou would provideRepresentative materialEUTECNIQ would doFormats and stability, where useful6. U.S. routeYou would provideCapacity, lead times, minimum order, pricing andtrade termEUTECNIQ would doPresents the ingredient to U.S. buyers under thechosen model; U.S. technical data packageQualified partnersCommercial counsel; customs brokers andwarehouses once goods moveEach step would be scoped and priced before it starts.Testing by external laboratories until EUTECNIQ has its own.
EUTECNIQ proposal. Inputs as listed in the table above; the steps follow the global ingredient pathway.
Text version of the steps and roles
  1. Gap assessmentYour documents against U.S. rules and buyer expectations
  2. QualificationAudit, corrective actions, draft quality agreement
  3. VerificationIndependent testing, fingerprint, specification
  4. Regulatory strategyCategory, NDI status, claims limits, import roles
  5. Application workFormats and stability, where useful
  6. U.S. routeDistribution, representation, co-development or private label
EUTECNIQ, proposed
  • Plans the work and owns the gap assessment and specification
  • Reviews all laboratory data and audit findings
  • Prepares the regulatory market-access file and U.S. technical data package
  • Presents the ingredient to U.S. buyers under the chosen model
Proposed
Qualified partners
  • External laboratories for identity, fingerprint, contaminant and stability testing
  • Third-party auditors where an on-site audit is needed and EUTECNIQ cannot attend
  • Regulatory and commercial counsel for legal conclusions and agreements
  • Customs brokers and warehouses once goods move
External partner
Documents produced

Each step ends in a named document whose ownership is agreed before the work starts

Default ownership is a starting proposal for negotiation.

Eight documents, grouped by who would own each by defaultProposed defaults
Eight documents the engagement would produce, grouped by their proposed default owner: supplier, shared, set by the agreement, the party that paid, or both partiesSupplierGap assessment reportWhen the supplier pays foritU.S. technical datapackageData sheets, allergen andcomposition statements,certificate templateSharedSupplier qualificationdossierBuyers see it only with thesupplier's consentSet by the agreementIngredient identitypassportSpecification withjustificationEUTECNIQ under privatelabelRegulatorymarket-access fileIncluding rights toreference itParty that paidVerification testsummaryIndependent resultscompared with yourcertificatesBoth partiesCommercial term sheetModel, territory, exclusivity,minimums, pricing, termDefault owner: a starting proposal for negotiation. EUTECNIQ's methods, templates and know-how would remain its background IP.Documents by proposed default ownerOwner: Supplier•Gap assessment report (When the supplier pays forit)•U.S. technical data package (Data sheets, allergenand composition statements, certificate template)Owner: Shared•Supplier qualification dossier (Buyers see it only withthe supplier's consent)Owner: Set by the agreement•Ingredient identity passport•Specification with justification (EUTECNIQ underprivate label)•Regulatory market-access file (Including rights toreference it)Owner: Party that paid•Verification test summary (Independent resultscompared with your certificates)Owner: Both parties•Commercial term sheet (Model, territory, exclusivity,minimums, pricing, term)
Names are proposed EUTECNIQ deliverables, not certifications or regulatory approvals.
Text version: contents and default ownership of each document
DocumentContentsProposed default ownership
Gap assessment reportWhat U.S. buyers and rules need, what exists, what is missing, and the cost and time to close each gapSupplier, when the supplier pays for it
Supplier qualification dossierAudit findings and corrective actions, manufacturing controls, draft quality agreement, traceability descriptionShared; buyers see it only with the supplier's consent
Ingredient identity passportAuthentication basis, plant part and source, fingerprint, specification, reference materialsSet by the agreement
Specification with justificationEach limit for identity, purity, strength, composition and contaminants, with its method and reasonSet by the agreement; under private label, EUTECNIQ
Verification test summaryIndependent results on several lots compared with your certificates of analysisParty that paid for the testing
Regulatory market-access fileIntended-use category, NDI status memo, claims boundaries, FSVP role plan, draft notification where neededSet by the agreement, including rights to reference it
U.S. technical data packageTechnical and safety data sheets, allergen and composition statements, certificate templateSupplier
Commercial term sheetModel, territory, exclusivity scope, minimums, pricing mechanism, termBoth parties

Who may file a new dietary ingredient notification: the manufacturer or distributor of the ingredient or of the supplement (21 CFR 190.6(a)). EUTECNIQ's methods, templates and know-how would remain its background IP; see commercialization and licensing.

Decision points

Six decisions would let either side stop early, before cost accumulates

Each decision would be taken on written evidence; stopping is a normal outcome.

Either side could stop at any of six decisions, before cost accumulatesProposed decisions
Six proposed decisions that let either side stop early, each with what happens if the answer is noQuestionIf the answer is no1Initial fit: is there a plausible U.S. use and buyer group?Before any NDADecline politelyNothing confidential exchangedNo2Scope and fee: after document review, is the gap closableat a cost both accept?After the gap assessmentStopThe summary of gaps is sharedNo3Qualification: do the audit and verification tests supportapproval?Audit and independent testsCorrective actions and retest, or stopNo4Regulatory pathway: is there a lawful U.S. route withproducible evidence?For the intended useChange the use, plan the evidence, or stopNo5Commercial model: which model, exclusivity, minimumsand term?Distribution, representation, co-development or private labelKeep the documentsNo distribution agreementNo fit6First commercial lots: do they clear entry, meetspecification on receipt and pass customer qualification?After the first shipmentsInvestigation and corrective actionBefore further shipmentsNoSix proposed decisions that let either side stop early, each with what happens if the answer is no1Initial fit: is there a plausible U.S. use andbuyer group?Before any NDADecline politelyNothing confidential exchangedNo2Scope and fee: after document review, is thegap closable at a cost both accept?After the gap assessmentStopThe summary of gaps is sharedNo3Qualification: do the audit and verificationtests support approval?Audit and independent testsCorrective actions and retest, or stopNo4Regulatory pathway: is there a lawful U.S.route with producible evidence?For the intended useChange the use, plan the evidence, or stopNo5Commercial model: which model, exclusivity,minimums and term?Distribution, representation, co-development orprivate labelKeep the documentsNo distribution agreementNo fit6First commercial lots: do they clear entry,meet specification on receipt and passcustomer qualification?After the first shipmentsInvestigation and corrective actionBefore further shipmentsNo
EUTECNIQ proposal. Documents produced up to a stop remain usable under the agreed ownership.
Text version of the six decisions
DecisionQuestionIf the answer is no
1. Initial fitDoes the ingredient have a plausible U.S. use and buyer group?Decline politely, before any NDA
2. Scope and feeAfter document review, is the gap closable at a cost both sides accept?Stop; the summary of gaps is shared
3. QualificationDo the audit and verification tests support approval?Corrective actions and retest, or stop
4. Regulatory pathwayIs there a lawful U.S. pathway for the intended use with evidence that can be produced?Change the intended use, plan the evidence, or stop
5. Commercial modelWhich model fits, with what exclusivity, minimums and term?Keep the documents; no distribution agreement
6. First commercial lotsDo lots clear entry, meet specification on receipt and pass customer qualification?Investigation and corrective action before further shipments
Rules that apply

Twenty-six CFR rule sets touch an imported botanical ingredient; most are duties of your U.S. importer or buyer

CFR rule sets for a botanical ingredient shipment, by agency and sized by length in eCFR; select a part to open iteCFR counts

Area is the number of sections in eCFR, a measure of length, not of importance; "*" marks rules that apply only in the circumstances they name. Select a part to open it in eCFR.Applicability as mapped on the CFR atlas for a bulk dietary ingredient that is imported; section counts from the eCFR API, up to date as of October 21, 2026. Orientation, not legal advice.
Data table: every rule set in the treemap
CFR parts for a botanical ingredient shipment entering the United States: A shipment of botanical ingredient entering the United States (eCFR section counts)
Rule setWhat it coversAgency groupeCFR sectionsLevel
21 CFR Part 111Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. CGMP for anyone who makes, packages, labels or holds a dietary supplement, including identity tests of dietary ingredients.FDA · 21 CFR84Check
21 CFR Part 117Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food. CGMP, hazard analysis and preventive controls for human food, including dietary ingredients.FDA · 21 CFR61Applies
21 CFR Part 101Food Labeling. Food labels: Supplement Facts (§ 101.36), health claims (§ 101.14) and structure/function statements (§ 101.93).FDA · 21 CFR50Check
21 CFR Part 1, Subpart RLaboratory Accreditation for Analyses of Foods. Certain food tests, such as tests to support admission of an import, must be run by a LAAF-accredited laboratory.FDA · 21 CFR42Check
21 CFR Part 1, Subpart OSanitary Transportation of Human and Animal Food. Shippers, loaders, carriers and receivers keep food safe during transport; § 1.900(b) lists exempt operations.FDA · 21 CFR18Check
21 CFR Part 1, Subpart LForeign Supplier Verification Programs for Food Importers. Importers verify that foreign suppliers produce food safely; § 1.511 modifies the program for dietary supplements.FDA · 21 CFR15Applies
21 CFR Part 1, Subpart HRegistration of Food Facilities. Facilities that make, process, pack or hold food for U.S. consumption register with FDA and renew every two years.FDA · 21 CFR14Applies
21 CFR Part 1, Subpart JEstablishment, Maintenance, and Availability of Records. Keep records of the immediate previous source and the immediate subsequent recipient of food.FDA · 21 CFR13Applies
21 CFR Part 1, Subpart DElectronic Import Entries. Lists the data FDA needs in each electronic customs entry of an FDA-regulated article.FDA · 21 CFR12Applies
21 CFR Part 1, Subpart IPrior Notice of Imported Food. Imported food needs prior notice to FDA: at least 2 hours before arrival by road, 4 by rail or air, 8 by water.FDA · 21 CFR10Applies
21 CFR Part 7, Subpart CEnforcement Policy. FDA's recall policy: recalls are voluntary actions, classified by health hazard, with a recall strategy.FDA · 21 CFR10Check
21 CFR Part 11Electronic Records; Electronic Signatures. Electronic records and signatures that meet FDA record rules must be trustworthy, reliable and equivalent to paper.FDA · 21 CFR10Applies
21 CFR Part 1, Subpart EImports and Exports. FDA import sampling, hearings and relabeling of refused goods, and the records kept for certain exports.FDA · 21 CFR9Check
21 CFR Part 190Dietary Supplements. A new dietary ingredient needs notification to FDA at least 75 days before marketing, unless the food-supply exception applies.FDA · 21 CFR1Check
19 CFR Part 141Entry of Merchandise. Entry of merchandise: liability for duties, who may enter, invoices, duty deposits and release.Trade: CBP, OFAC, FWS69Applies
19 CFR Part 113CBP Bonds. Customs bonds that secure payment of duties and compliance with import rules.Trade: CBP, OFAC, FWS53Applies
19 CFR Part 142Entry Process. The entry process: entry documents, entry summary, immediate delivery and line release.Trade: CBP, OFAC, FWS40Applies
19 CFR Part 134Country of Origin Marking. Country-of-origin marking of imported articles or their containers (§ 134.11).Trade: CBP, OFAC, FWS33Applies
19 CFR Part 177Administrative Rulings. Binding advance rulings from CBP, for example on tariff classification.Trade: CBP, OFAC, FWS25Check
19 CFR Part 152Classification and Appraisement of Merchandise. Tariff classification and customs valuation of imported goods.Trade: CBP, OFAC, FWS21Applies
19 CFR Part 12 (selected subject groups)Special Classes of Merchandise. CBP rules for FDA-regulated goods (§ 12.1), plants, goods made with forced labor, and goods under sanctions.Trade: CBP, OFAC, FWS16Applies
19 CFR Part 149Importer Security Filing. Importer Security Filing for ocean cargo; core data due 24 hours before loading at the foreign port.Trade: CBP, OFAC, FWS6Check
7 CFR Part 319Foreign Quarantine Notices. Conditions for importing plants and plant products that can carry pests; they depend on the commodity and origin.USDA · 7 CFR128Check
7 CFR Part 330Federal Plant Pest Regulations; General; Plant Pests, Biological Control Organisms, and Associated Articles; Garbage. Restrictions on moving plant pests, biological control organisms and associated articles, and on garbage.USDA · 7 CFR24Check
7 CFR Part 357Control of Illegally Taken Plants. Lacey Act plant declaration (§ 357.3): required for tariff codes on APHIS's phase-in schedule; "plant" excludes common cultivars and common food crops (§ 357.2). CFR atlasUSDA · 7 CFR4Check
40 CFR Part 180Tolerances and Exemptions for Pesticide Chemical Residues in Food. Tolerances and exemptions for pesticide residues in food; inert-ingredient exemptions are in §§ 180.910–180.960.EPA · 40 CFR755Applies
Total26 rule sets; 14 apply, the rest apply only in the circumstances they name15231122 in rules that apply
What is not promised

No regulatory outcome, sale or exclusivity would be promised before evidence and a signed agreement exist

Eight things a supplier should not read into the proposed serviceStatute and regulation Proposed terms
  • FDA's acknowledgment of a notification≠FDA approval of the ingredient
  • FDA's silence on a notification≠A finding that the ingredient is safe (21 CFR 190.6(f))
  • A GRAS conclusion≠A conclusion that cannot be challenged
  • Work toward U.S. buyers≠A promised volume, price, customer or exclusivity
  • A report from EUTECNIQ≠A certification
  • EUTECNIQ's support≠A transfer of your duties: facility registration, manufacturing practice, data accuracy
  • A foreign GMP certificate or U.S. status≠U.S. marketability, or status in any other market
  • Your certificate of analysis≠A buyer's own identity test (21 CFR 111.75(a)(1))
21 CFR 190.6(f): failure of FDA to respond to a notification "does not constitute a finding" that the ingredient is safe; 21 CFR 111.75(a)(1): a supplement manufacturer tests the identity of each dietary ingredient itself. Terms are EUTECNIQ proposals.
Text version: the five limits
  • No regulatory outcome. FDA approves neither dietary ingredients nor notifications; its silence is not a finding of safety. A GRAS conclusion can be challenged.
  • No volume, price, customer or exclusivity before a signed agreement.
  • No certification: reports would be evidence for buyers.
  • Your duties stay yours: facility registration, manufacturing practice, data accuracy.
  • One market at a time: U.S. work does not establish status elsewhere.
Confidentiality

Nothing confidential would be requested before a mutual NDA is signed

Confidential information would move in five stages, each with a purpose and an access listProposed 21 CFR 190.6(e)
Five proposed confidentiality stages, from a non-confidential summary to the planning of what is marked before an FDA filingFirst contactMutual NDAData roomDevelopment agreementBefore any filingA non-confidential summaryonlyNon-confidentialDefines confidentialinformation; evaluation useonly; no analysis beyond theagreed tests; term; return ordestructionConfidentialDossiers, process detailsand audit reports in acontrolled folder with accessloggingConfidentialOwnership of new data andreports; rights to referencethem in regulatory files;publication only withconsentContractFDA keeps an NDInotification confidential for90 days, then publishes itexcept trade secrets andconfidential commercialinformation; marking isplanned before filing21 CFR 190.6(e)EUTECNIQ would not use one supplier's confidential data for another supplier's product.Five proposed confidentiality stages, from a non-confidential summary to the planning of what is marked before an FDA filing1. First contactA non-confidential summary onlyNon-confidential2. Mutual NDADefines confidential information; evaluation use only;no analysis beyond the agreed tests; term; return ordestructionConfidential3. Data roomDossiers, process details and audit reports in acontrolled folder with access loggingConfidential4. Development agreementOwnership of new data and reports; rights toreference them in regulatory files; publication onlywith consentContract5. Before any filingFDA keeps an NDI notification confidential for 90 days,then publishes it except trade secrets and confidentialcommercial information; marking is planned beforefiling21 CFR 190.6(e)EUTECNIQ would not use one supplier's confidential data foranother supplier's product.
21 CFR 190.6(e): an NDI notification is kept confidential for 90 days, then made public except trade secrets and confidential commercial information.
Text version of the five stages
  1. First contact. A non-confidential summary only.
  2. Mutual NDA. Defines confidential information, use for evaluation only, no analysis of samples beyond the agreed tests, term, and return or destruction.
  3. Data room. Dossiers, process details and audit reports shared in a controlled folder with access logging.
  4. Development agreement. Ownership of new data and reports, rights to reference them in regulatory files, and publication only with consent.
  5. Before any filing. FDA keeps a new dietary ingredient notification confidential for 90 days, then makes it public except trade secrets and confidential commercial information (21 CFR 190.6(e)). What is marked confidential is planned before filing.

EUTECNIQ would not use one supplier's confidential data for another supplier's product.

Start with a non-confidential summary

Send the ingredient, plant species and part, form, intended U.S. uses and existing certifications. A reply would say whether there is a fit and propose an NDA.